Who will be blinded {17a}
Trial participants, trial staff, healthcare providers, outcome assessors and data analysts will be blinded. The trial treatment packs will look identical except for the unique randomisation number. All women will receive two IM injections and one IV injection to ensure blinding of the route of tranexamic acid administration. The IM and IV treatment kits within each treatment pack will be clearly labelled to show the intended route of administration.